Activist Firm Re-Iterates Delcath Systems to Put Itself for Sale & Cut Excess Compensation

Delcath Systems Trades Significantly Below It's Net Cash Value Per Share & Would Be a Great Fit Within a Large Pharma but Not Independent
By: Linkedto Partners
 
NEW YORK - Sept. 3, 2014 - PRLog -- Activist Firm Re-Iterates Call for Delcath Systems to Put Itself for Sale & Cut Excess Compensation Immediately

Dear Delcath Systems and Investors:

Linkedto Partners currently owns 77,425 shares of Delcath System's (DCTH) common stock.

Our firm owns more shares than most executives of this company.

We urge the company to listen to shareholders and conduct an exploration to put up the company for sale.

Delcath Systems has maintained a strong cash position, but excess salaries and poor decisions from prior management have created an untenable situation.

The company needs to act quickly as it is burning cash.  The way to stop burning cash is to cut your salaries and return some cash to shareholders.

We are pretty sure if you put the company up for sale it will attract some major pharma companies interested in Europe and American sales.

The time to act is now when the healthcare companies are considering a lot of M&A deals.

We look forward to hearing back from Delcath Systems soon and speaking with other major shareholders soon.

Regards,

Neil Fromer

Linkedto Partners

Contact:

Jon Sanders

Bayt Trust

jonathansand@bayttrust.com

+1.206.202.7703

Media Contact
Jon Sanders
***@bayttrust.com
2062027703
End
Source:Linkedto Partners
Email:***@bayttrust.com Email Verified
Tags:Delcath, Activist, Shareholders, M A
Industry:Financial, Investment
Location:New York City - New York - United States
Subject:Projects
Account Phone Number Verified     Disclaimer     Report Abuse
Bayt Trust News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share